Christina Pellicane

Position
Lead Instructor
Bio/Description

Christina Pellicane is COO at Lignolix, a chemical tech startup, as well as a part-time Expert at the National Science Foundation and an independent consultant, specializing in entrepreneurship education, for institutions/programs such as Princeton University, Canada's Lab2Market accelerator and VentureWell. She is a nationally certified NSF I-Corps Instructor and Lean Launchpad teacher and coach at schools and incubators around the world.

Previously, Ms. Pellicane served as the first-ever Director of Commercialization for the University of Delaware (UD) Horn Entrepreneurship Center with Board members such as Pat Riley, CEO of the Global Accelerator Network and GAN Ventures, Tanya Bakalov, CEO of SevOne and Kris Vaddi, CEO of Prelude (NASDAQ:PRLD). In this role, she developed and/or managed several initiatives including a $2M Proof of Concept program, the Horn Venture Mentoring Service and the UD I-Corps Site. Prior to UD, she served as the first Executive Manager of the NYC Regional I-Corps Node, funded by NSF for nearly $4M, led by CUNY in partnership with NYU and Columbia. She also served as CUNY’s manager of the PowerBridgeNY cleantech accelerator, funded by NYSERDA for $10M, with top-tier NYC institutions such as Columbia University, Brookhaven National Laboratory and Cornell Tech. Before helping scientists become entrepreneurs, she was one herself. Ms. Pellicane held positions as a Clinical Business Administrator and Study Monitor at a veterinary clinical research organization, AlcheraBio, and a Research Associate at a biotech startup, Venenum Biodesign. Christina has also been an independent consultant through her company Antevasin with projects including the U.S. Department of State’s Global Innovation through Science and Technology (GIST) with VentureWell and The New York Academy of Sciences’ NYSERDA Proof of Concept Center Metrics and Evaluation Project.

Ms. Pellicane is a patented inventor and holds a B.S. in Biology and Animal Science from the University of Georgia and a Master of Business and Science with a concentration in Biotechnology and Genomics from Rutgers University.